Factors associated with adverse outcomes among SARS-CoV-2 positive children in a Tertiary Government COVID-19 Referral Hospital in the Philippines

Mark Jason DC Milan; Al Joseph R Molina; Anna Lisa T Ong-lim; Ma Esterlita V Uy; Herbert G Uy

Return

Factors associated with adverse outcomes among SARS-CoV-2 positive children in a Tertiary Government COVID-19 Referral Hospital in the Philippines

Author: Mark Jason DC. Milan ¹ ; Al Joseph R. Molina ² ; Anna Lisa T. Ong-Lim ³ ; Ma. Esterlita V. Uy ⁴ ; Herbert G. Uy ⁵
Author Information

1. Department of Pediatrics, Philippine General Hospital, University of the Philippines Manila
2. Expanded Hospital Research Office, Philippine General Hospital, University of the Philippines Manila
3. Division of Infectious and Tropical Diseases, Department of Pediatrics, Philippine General Hospital, University of the Philippines Manila
4. Division of Newborn Medicine, Department of Pediatrics, Philippine General Hospital, University of the Philippines Manila
5. Division of Pediatric Critical Care, Department of Pediatrics, Philippine General Hospital, University of the Philippines Manila
Publication Type:Journal Article
Keywords: Hazards
MeSH: COVID-19; Epidemiology; Philippines; Child; Pediatrics
From: Acta Medica Philippina 2024;58(7):73-89
CountryPhilippines
Language:English
Abstract: Background and Objective:Pediatric COVID-19 epidemiology and factors associated with adverse outcomes-mortality, need for invasive mechanical ventilation, and ICU admission, are largely unstudied. We described the clinicodemographic characteristics of Filipino pediatric COVID-19 patients and determined the factors associated with adverse outcomes.
Methods:This is a retrospective cohort study of 180 hospitalized SARS-CoV-2-confirmed cases 0-18 years old from April 2020 to August 2021 in a tertiary COVID-19 referral hospital in Manila, National Capital Region. Crude associations were determined using chi-squared or Fisher’s exact tests; and medians were compared using the Mann-Whitney test. Factors predictive of mortality were determined using Cox proportional hazards regression analysis. The survivor functions were depicted in graphs.
Results:About 41.67% had mild disease, 58.33% were males, 39.4% aged 0-4 years, and 69.44% had at least one comorbidity. About 9.44% died (adjusted 9.2 persons per 1000 patient-days, 95% CI 5.5%-15.2%), 17.78% needed invasive mechanical ventilation, and 20% needed ICU admission. Independently, severe-critical COVID-19 (HRc 11.51, 95% CI 3.23, 41.06), retractions (HRc 10.30, 95% CI 3.27, 32.47), alar flaring (HRc 4.39, 95% CI 1.53, 12.58), cyanosis (HRc 4.39, 95% CI 1.72, 14.11), difficulty of breathing (HRc 7.99, 95% CI 2.25, 28.71), poor suck/appetite (HRc 4.46, 95% CI 1.59, 12.40), ferritin (HRc 1.01, 95% CI 1.00, 1.01), IL-6 (HRc 1.01, 95% CI 1.00, 1.01), aPTT (HRc 1.05, 95% CI 1.01, 1.10), IVIg (HRc 4.00, 95% CI 1.07, 14.92) and corticosteroid (HRc 6.01, 95% CI 2.04, 17.67) were significant hazards for mortality. In adjusted Cox analysis, only retractions (HRa 34.96, 95% CI 3.36, 363.79), seizure (HRa 9.98, 95% CI 1.76, 56.55), and corticosteroids (HRa 8.21, 95% CI 1.12, 60.38) were significantly associated with mortality while alar flaring appeared to be protective (HRa 0.10, 95% CI 0.01, 0.95). Several clinical characteristics were consistently associated with adverse outcomes.
Conclusions:Majority of hospitalized pediatric COVID-19 patients were very young, males, had mild disease, and had at least one comorbidity. Mortality, invasive mechanical ventilation, and ICU admission were relatively low. Except for alar flaring which appeared to be protective, retractions, seizure, and use of corticosteroids were associated with adverse outcomes.
Full text:8392-Article Text-155755-1-10-20240430.pdf